Papillary Thyroid Carcinoma Treatment Market, Global Outlook and Forecast 2023-2029

Report ID: MMG194233 | Category: Medical Devices & Consumables | Pages: 69 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Papillary cancer and its variants. Most cancers are treated with removal of the thyroid gland (thyroidectomy), although small tumors that have not spread outside the thyroid gland may be treated by just removing the side of the thyroid containing the tumor (lobectomy).
This report aims to provide a comprehensive presentation of the global market for Papillary Thyroid Carcinoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Papillary Thyroid Carcinoma Treatment. This report contains market size and forecasts of Papillary Thyroid Carcinoma Treatment in global, including the following market information:
Global Papillary Thyroid Carcinoma Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Papillary Thyroid Carcinoma Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Surgery Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Papillary Thyroid Carcinoma Treatment include Abbott Laboratories, Roche Holding AG, Thermo Fisher Scientific Inc, Siemens Healthineers, Bio-Rad Laboratories, Agilent Technologies, Illumina, Hologic and Leica Biosystems Nussloch GmbH, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Papillary Thyroid Carcinoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Papillary Thyroid Carcinoma Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Papillary Thyroid Carcinoma Treatment Market Segment Percentages, by Type, 2022 (%)
    Surgery
    Iodine Therapy
    Thyroxin Treatment
    External Radiotherapy
    Chemotherapy
    Other
Global Papillary Thyroid Carcinoma Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Papillary Thyroid Carcinoma Treatment Market Segment Percentages, by Application, 2022 (%)
    Hospital
    Clinics
    Others
Global Papillary Thyroid Carcinoma Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Papillary Thyroid Carcinoma Treatment Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Papillary Thyroid Carcinoma Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Papillary Thyroid Carcinoma Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Abbott Laboratories
    Roche Holding AG
    Thermo Fisher Scientific Inc
    Siemens Healthineers
    Bio-Rad Laboratories
    Agilent Technologies
    Illumina
    Hologic
    Leica Biosystems Nussloch GmbH
    FUJIFILM Holdings Corporation
    Merck KGaA
    Beckman Coulter
    Randox Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Papillary Thyroid Carcinoma Treatment, market overview.
Chapter 2: Global Papillary Thyroid Carcinoma Treatment market size in revenue.
Chapter 3: Detailed analysis of Papillary Thyroid Carcinoma Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Papillary Thyroid Carcinoma Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Papillary Thyroid Carcinoma Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Papillary Thyroid Carcinoma Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Papillary Thyroid Carcinoma Treatment Overall Market Size
    2.1 Global Papillary Thyroid Carcinoma Treatment Market Size: 2022 VS 2029
    2.2 Global Papillary Thyroid Carcinoma Treatment Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Papillary Thyroid Carcinoma Treatment Players in Global Market
    3.2 Top Global Papillary Thyroid Carcinoma Treatment Companies Ranked by Revenue
    3.3 Global Papillary Thyroid Carcinoma Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Papillary Thyroid Carcinoma Treatment Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Papillary Thyroid Carcinoma Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Papillary Thyroid Carcinoma Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Papillary Thyroid Carcinoma Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Papillary Thyroid Carcinoma Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Papillary Thyroid Carcinoma Treatment Market Size Markets, 2022 & 2029
        4.1.2 Surgery
        4.1.3 Iodine Therapy
        4.1.4 Thyroxin Treatment
        4.1.5 External Radiotherapy
        4.1.6 Chemotherapy
        4.1.7 Other
    4.2 By Type - Global Papillary Thyroid Carcinoma Treatment Revenue & Forecasts
        4.2.1 By Type - Global Papillary Thyroid Carcinoma Treatment Revenue, 2018-2023
        4.2.2 By Type - Global Papillary Thyroid Carcinoma Treatment Revenue, 2024-2029
        4.2.3 By Type - Global Papillary Thyroid Carcinoma Treatment Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Papillary Thyroid Carcinoma Treatment Market Size, 2022 & 2029
        5.1.2 Hospital
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Papillary Thyroid Carcinoma Treatment Revenue & Forecasts
        5.2.1 By Application - Global Papillary Thyroid Carcinoma Treatment Revenue, 2018-2023
        5.2.2 By Application - Global Papillary Thyroid Carcinoma Treatment Revenue, 2024-2029
        5.2.3 By Application - Global Papillary Thyroid Carcinoma Treatment Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Papillary Thyroid Carcinoma Treatment Market Size, 2022 & 2029
    6.2 By Region - Global Papillary Thyroid Carcinoma Treatment Revenue & Forecasts
        6.2.1 By Region - Global Papillary Thyroid Carcinoma Treatment Revenue, 2018-2023
        6.2.2 By Region - Global Papillary Thyroid Carcinoma Treatment Revenue, 2024-2029
        6.2.3 By Region - Global Papillary Thyroid Carcinoma Treatment Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Papillary Thyroid Carcinoma Treatment Revenue, 2018-2029
        6.3.2 US Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.3.3 Canada Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.3.4 Mexico Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Papillary Thyroid Carcinoma Treatment Revenue, 2018-2029
        6.4.2 Germany Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.4.3 France Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.4.4 U.K. Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.4.5 Italy Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.4.6 Russia Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.4.7 Nordic Countries Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.4.8 Benelux Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Papillary Thyroid Carcinoma Treatment Revenue, 2018-2029
        6.5.2 China Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.5.3 Japan Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.5.4 South Korea Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.5.5 Southeast Asia Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.5.6 India Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Papillary Thyroid Carcinoma Treatment Revenue, 2018-2029
        6.6.2 Brazil Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.6.3 Argentina Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Papillary Thyroid Carcinoma Treatment Revenue, 2018-2029
        6.7.2 Turkey Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.7.3 Israel Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.7.4 Saudi Arabia Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
        6.7.5 UAE Papillary Thyroid Carcinoma Treatment Market Size, 2018-2029
7 Papillary Thyroid Carcinoma Treatment Companies Profiles
    7.1 Abbott Laboratories
        7.1.1 Abbott Laboratories Company Summary
        7.1.2 Abbott Laboratories Business Overview
        7.1.3 Abbott Laboratories Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.1.4 Abbott Laboratories Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.1.5 Abbott Laboratories Key News & Latest Developments
    7.2 Roche Holding AG
        7.2.1 Roche Holding AG Company Summary
        7.2.2 Roche Holding AG Business Overview
        7.2.3 Roche Holding AG Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.2.4 Roche Holding AG Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.2.5 Roche Holding AG Key News & Latest Developments
    7.3 Thermo Fisher Scientific Inc
        7.3.1 Thermo Fisher Scientific Inc Company Summary
        7.3.2 Thermo Fisher Scientific Inc Business Overview
        7.3.3 Thermo Fisher Scientific Inc Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.3.4 Thermo Fisher Scientific Inc Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.3.5 Thermo Fisher Scientific Inc Key News & Latest Developments
    7.4 Siemens Healthineers
        7.4.1 Siemens Healthineers Company Summary
        7.4.2 Siemens Healthineers Business Overview
        7.4.3 Siemens Healthineers Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.4.4 Siemens Healthineers Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.4.5 Siemens Healthineers Key News & Latest Developments
    7.5 Bio-Rad Laboratories
        7.5.1 Bio-Rad Laboratories Company Summary
        7.5.2 Bio-Rad Laboratories Business Overview
        7.5.3 Bio-Rad Laboratories Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.5.4 Bio-Rad Laboratories Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.5.5 Bio-Rad Laboratories Key News & Latest Developments
    7.6 Agilent Technologies
        7.6.1 Agilent Technologies Company Summary
        7.6.2 Agilent Technologies Business Overview
        7.6.3 Agilent Technologies Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.6.4 Agilent Technologies Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.6.5 Agilent Technologies Key News & Latest Developments
    7.7 Illumina
        7.7.1 Illumina Company Summary
        7.7.2 Illumina Business Overview
        7.7.3 Illumina Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.7.4 Illumina Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.7.5 Illumina Key News & Latest Developments
    7.8 Hologic
        7.8.1 Hologic Company Summary
        7.8.2 Hologic Business Overview
        7.8.3 Hologic Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.8.4 Hologic Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.8.5 Hologic Key News & Latest Developments
    7.9 Leica Biosystems Nussloch GmbH
        7.9.1 Leica Biosystems Nussloch GmbH Company Summary
        7.9.2 Leica Biosystems Nussloch GmbH Business Overview
        7.9.3 Leica Biosystems Nussloch GmbH Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.9.4 Leica Biosystems Nussloch GmbH Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.9.5 Leica Biosystems Nussloch GmbH Key News & Latest Developments
    7.10 FUJIFILM Holdings Corporation
        7.10.1 FUJIFILM Holdings Corporation Company Summary
        7.10.2 FUJIFILM Holdings Corporation Business Overview
        7.10.3 FUJIFILM Holdings Corporation Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.10.4 FUJIFILM Holdings Corporation Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.10.5 FUJIFILM Holdings Corporation Key News & Latest Developments
    7.11 Merck KGaA
        7.11.1 Merck KGaA Company Summary
        7.11.2 Merck KGaA Business Overview
        7.11.3 Merck KGaA Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.11.4 Merck KGaA Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.11.5 Merck KGaA Key News & Latest Developments
    7.12 Beckman Coulter
        7.12.1 Beckman Coulter Company Summary
        7.12.2 Beckman Coulter Business Overview
        7.12.3 Beckman Coulter Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.12.4 Beckman Coulter Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.12.5 Beckman Coulter Key News & Latest Developments
    7.13 Randox Laboratories
        7.13.1 Randox Laboratories Company Summary
        7.13.2 Randox Laboratories Business Overview
        7.13.3 Randox Laboratories Papillary Thyroid Carcinoma Treatment Major Product Offerings
        7.13.4 Randox Laboratories Papillary Thyroid Carcinoma Treatment Revenue in Global Market (2018-2023)
        7.13.5 Randox Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Papillary Thyroid Carcinoma Treatment Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?